Skip to main content
Renalytix Plc (AIM:RENX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1.785
-0.015 (-0.83%)
Apr 29, 2026, 12:50 PM GMT

Renalytix Revenue

Renalytix had revenue of $800.00K USD in the quarter ending December 31, 2025, with 36.52% growth. This brings the company's revenue in the last twelve months to $3.30M, up 40.31% year-over-year. In the fiscal year ending June 30, 2025, Renalytix had annual revenue of $3.00M with 30.43% growth.

Revenue (ttm)
$3.30M
Revenue Growth
+40.31%
P/S Ratio
3.21
Revenue / Employee
$71.74K
Employees
46
Market Cap
7.87M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20253.00M700.00K30.43%
Jun 30, 20242.30M-1.10M-32.41%
Jun 30, 20233.40M433.00K14.58%
Jun 30, 20222.97M1.48M99.20%
Jun 30, 20211.49M--
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.64B
GSK plc 32.67B
Haleon 11.03B
Smith & Nephew 4.58B
CelLBxHealth 2.62M
Oxford BioDynamics 1.10M
GENinCode 2.91M
Verici Dx 1.40M
Revenue Rankings

Renalytix News

More News